CBPO [China Biologic Products] 10-Q:

[] [STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,] [Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)] [CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant] [Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer]

MPEL [Melco Crown Entertainment] 6-K: Melco Crown Entertainment Announces Unaudited Second Quarter 2016

[Melco Crown Entertainment Announces Unaudited Second Quarter 2016 Earnings and Declares Quarterly Dividend Macau, Thursday, August 4, 2016 Melco Crown Entertainment Company we Net revenue for the second quarter of 2016 was US$1,070.4 million, representing an increase of approximately 17% from US$916.8 million for the comparable period in 2015. The increase in net revenue was primarily attributable to the net] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]

By | 2016-08-05T02:08:17+00:00 August 4th, 2016|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] 25-NSE: .FormData {color: blue; background-color: white; font-size: small; font-family:

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:] []

NPD [China Nepstar Chain Drugstore] SC 13D/A: (1) This CUSIP number applies to the Issuer’s

[(1) This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares. 1. Name of Reporting Person Simin Zhang 2. Check the Appropriate Box if A Member of A Group (a) (b) 3. SEC Use Only 4. Source of Funds PF and BK 5 6. Citizenship or Place of Organization People’s Republic of China Number of]

SSW [Seaspan] FWP: Registration No. 333-211545 SUMMARY OF FINAL TERMS August

[Registration No. 333-211545 SUMMARY OF FINAL TERMS August 4, 2016 $225,000,000 SEASPAN CORPORATION 7.875% SERIES H CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated August 4, 2016, relating to these securities and supersedes the information in the]

SSW [Seaspan] 6-K: Seaspan Corporation nd Unit 2, 2 141 Connaught

[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 – 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Pricing of $225 Million Public Offering of 7.875% Series H Cumulative Redeemable Perpetual Preferred Shares HONG KONG, CHINA, August 4, 2016 – Seaspan Corporation (“Seaspan”) (NYSE:SSW) announced today that] [Item 1 — Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d208866d6k.htm FORM 6-K]

SSW [Seaspan] 6-K: Seaspan Corporation nd Unit 2, 2 141 Connaught

[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 – 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Public Offering of Series H Cumulative Redeemable Perpetual Preferred Shares Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley, J.P. Morgan, RBC Capital Markets and Citigroup Global Markets Inc.] [Item 1 — Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d226290d6k.htm FORM 6-K]

SSW [Seaspan] 424B5: This document is in two parts. The first

[This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the “prospectus,” we are referring to both parts combined. If information in]

ONP [Orient Paper] 8-K: Orient Paper, Inc. Announces Unaudited Preliminary Financial Results

[Orient Paper, Inc. Announces Unaudited Preliminary Financial Results for Second Quarter 2016 Company to Host Earnings Conference Call on Thursday, August 11, 2016, at 8:00 am ET Selected Second Quarter 2016 Financial Results (Unaudited and Preliminary) For the Three Months Ended June 30, 2016 2015 % Change Revenue ($M) $ 38.0 $ 41.3 -8.0 % Sales volume (tonnes) Regular Corrugating] []

LFC [CHINA LIFE INSURANCE CO] 6-K: CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock

[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT RESIGNATION OF NON-EXECUTIVE DIRECTOR Board Company The board of directors (the “ Mr. Zhang Xiangxian has confirmed that he has no disagreement with the Board and there are no other matters relating to his resignation that] [Description 99.1 Announcement, dated August 4, 2016 China Life Insurance Company Limited]

By | 2016-08-05T02:36:43+00:00 August 4th, 2016|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar